Wikidata

(Q65352503)

English

MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients

clinical trial

In more languages

Statements

short name
HERMIONE (English)
0 references
title
A Randomized, Multicenter, Open Label Study of MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in Anthracycline Naive Patients With Locally Advanced/Metastatic HER2-Positive Breast Cancer (English)
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
Czech Republic
0 references
France
0 references
Germany
0 references
Italy
0 references
Spain
0 references
start time
July 2014
0 references
end time
December 2016
0 references
number of participants
113
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65352503&oldid=1858218857"